Patents by Inventor Wenliang LAN

Wenliang LAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystal form of pyrrolidinyl urea derivative and application thereof
    Patent number: 11708357
    Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method thereof, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: July 25, 2023
    Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Fei Hong, Zhiliang Chen, Liju Wang, Jinxia Lin, Wenliang Lan, Yang Zhang, Wentao Wu, Zhixiang Li, Jian Qin
  • CRYSTAL FORM OF PYRROLIDINYL UREA DERIVATIVE AND APPLICATION THEREOF
    Publication number: 20230103409
    Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method therefor, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
    Type: Application
    Filed: January 8, 2021
    Publication date: April 6, 2023
    Applicants: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD., ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Fei HONG, Zhiliang CHEN, Liju WANG, Jinxia LIN, Wenliang LAN, Yang ZHANG, Wentao WU, Zhixiang LI, Jian QIN
  • 3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF
    Publication number: 20220119375
    Abstract: A 3-aryloxy-3-aryl-propylamine compound or a pharmaceutically acceptable salt of same, or a prodrug of same, and uses thereof. The compound has the structure of formula I. The compound, the pharmaceutically acceptable salt of same, or the prodrug of same provides an inhibitory effect with respect to a transient receptor potential (TRP) channel protein, and provides great therapeutic effects with respect to diseases related to the transient receptor potential channel protein.
    Type: Application
    Filed: August 16, 2019
    Publication date: April 21, 2022
    Inventors: Youxin WANG, Jinxia LIN, Zhiliang CHEN, Wenliang LAN, Lingling ZHANG, Zhenlin QU